JADE STATE WEALTH LIMITED

Company number 07688855 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: JADE STATE WEALTH LIMITED

1. Financial Health Score: D

Explanation: The patient is suffering from chronic balance sheet insolvency. While the company is not facing immediate cash flow cardiac arrest, its liabilities significantly exceed its assets, meaning it is technically insolvent on paper. The complete stagnation of both assets and liabilities between 2023 and 2024 suggests a dormant or "zombie" state rather than active, healthy trading.

2. Key Vital Signs

  • Net Assets (The Patient's "Weight"): £-19,770. The business is financially underweight, operating with negative equity. This indicates that if all creditors demanded payment today, the company's assets would not be sufficient to cover the debts.
  • Current Assets vs. Current Liabilities (Short-Term "Blood Pressure"): £154,580 vs. £0. Surprisingly, the short-term vital signs are perfectly stable. With no immediate creditors demanding payment, the company has excellent short-term liquidity and faces no risk of immediate cash flow heart failure.
  • Long-Term Debt (Financial "Cholesterol"): £404,350. The balance sheet is severely clogged with long-term creditors. This massive blockage is what tips the net assets into the negative.
  • Year-on-Year Movement (The "Pulse"): Flatlined. The balance sheet for 2023 and 2024 is completely identical down to the pound. The pulse is present, but the patient is not growing or moving financially.

3. Diagnosis

Chronic Balance Sheet Insolvency with Asymptomatic Short-Term Liquidity.

Looking at the medical history, the patient was perfectly healthy in 2017 with net assets of £140,499. By 2020, the condition deteriorated rapidly into negative equity (£-22,756), likely triggered by a significant withdrawal, distribution, or acquisition of long-term debt that was not supported by equivalent asset growth.

Today, the primary ailment is a £404,350 long-term debt that dwarfs the company's total assets (£384,580). However, because this debt is long-term and there are no current liabilities pressing for immediate payment, the company suffers no day-to-day cash flow symptoms. It is functioning as a "holding" entity (consistent with its SIC code), keeping assets on life support while carrying a heavy long-term debt burden. The "Lorem ipsum dolor" placeholder on the website further suggests the operational side of the business is dormant or inactive.

4. Recommendations

To restore this patient to full financial health, the following targeted interventions are recommended:

  • Debt Restructuring or Forgiveness: The long-term debt of £404,350 is the primary illness. If this debt is owed to the director (name shown to subscribers) or the parent corporate PSC (Accounting Worx Limited), it should be formally reclassified or partially forgiven to cure the negative equity and restore the balance sheet to health.
  • Asset Valation Check: The fixed assets are sitting at £230,000 with no movement year-on-year. A physical "examination" is needed to ensure these assets are not impaired. If they are worth more than book value, the equity position may be stronger than it appears on paper.
  • Capital Injection: If the debt cannot be forgiven, a capital injection (a financial "transfusion") from the shareholders is required to rebuild the equity base and cure the insolvency.
  • Re-evaluate Purpose: As a holding company with flatlined financial activity, the directors should assess whether the entity still serves a strategic purpose, or if it should be carefully wound down to reduce administrative burden.

Names of the people mentioned are shown to subscribers. See subscription

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 24 July 2026